文献速递免疫规划

抗体介导的免疫记忆与小鼠长期莱姆病兽医疫苗保护相关

Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice.
PubMed 文献 · Vaccine · 2024-06-26

研究用C3H/HeNCrl小鼠比较两种美国农业部批准的犬用莱姆病疫苗(Duramune细菌疫苗与Vanguard crLyme亚单位疫苗)的免疫应答和保护效果。两种疫苗均诱导抗伯氏疏螺旋体IgG抗体,但Vanguard组抗体水平随时间衰减;接种后120天Duramune保护优于Vanguard,伴更高抗体滴度、更多长寿命浆细胞和高亲和力抗体。

要点

  • 两种犬用莱姆病疫苗在小鼠模型中仅提供部分保护。
  • 接种后120天Duramune保护优于Vanguard,抗体滴度更高。
  • Vanguard组抗伯氏疏螺旋体抗体及抗OspA、OspC抗体水平随时间下降。

核心结论

  • 体液免疫记忆应答对莱姆病兽医疫苗保护具有重要意义,可为未来人用疫苗研发提供参考。

研究设计与样本

  • 小鼠模型研究,C3H/HeNCrl小鼠接受两剂Duramune或Vanguard疫苗,设短期(35天)和长期(120天)研究评估免疫应答与保护。

主要发现

  • 两种疫苗均诱导高滴度抗伯氏疏螺旋体IgG抗体,但Vanguard接种小鼠抗体水平随时间衰减。
  • 接种后120天Vanguard组抗OspA和抗OspC抗体水平低于Duramune组。
  • 两种疫苗在所用剂量下仅提供部分保护。
  • 接种后120天Duramune保护优于Vanguard,伴更高抗体滴度、更多长寿命浆细胞和高亲和力抗体。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lyme disease, caused by the bacterium Borrelia burgdorferi, is the most common tick-borne illness in the United States. Despite the rise in Lyme disease incidence, there is no vaccine against B. burgdorferi approved for human use. Little is known about the immune correlates of protection needed to prevent Lyme disease. In this work, a mouse model was used to characterize the immune response and compare the protection provided by two USDA-approved vaccines for use in canines: Duramune (bacterin vaccine) and Vanguard crLyme (subunit vaccine composed of two outer surface proteins, OspA and OspC). C3H/HeNCrl mice were immunized with two doses of either Duramune or Vanguard, and immune responses and protection against B. burgdorferi were assessed in short (35 days) and long-term (120 days) studies. Flow cytometry, ELISPOT detection of antibody-producing cells, and antibody affinity studies were performed to identify correlates of vaccine-mediated protection. Both vaccines induced humoral responses, with high IgG titers against B. burgdorferi. However, the levels of anti-B. burgdorferi antibodies decayed over time in Vanguard-vaccinated mice. While both vaccines triggered the production of antibodies against both OspA and OspC, antibody levels against these proteins were also lower in Vanguard-vaccinated mice 120 days post-vaccination. Both vaccines only provided partial protection against B. burgdorferi at the dose used in this model. The protection provided by Duramune was superior to Vanguard 120 days post-vaccination, and was characterized by higher antibody titers, higher abundance of long-lived plasma cells, and higher avidity antibodies than Vanguard. Overall, these studies provide insights into the importance of the humoral memory response to veterinary vaccines against Lyme disease and will help inform the development of future human vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gutierrez MP, Huckaby AB, Yang E, et al. Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice. Vaccine. 2024. PMID: 38937181. doi:10.1016/j.vaccine.2024.06.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。